SCHEMBL7603086

SCHEMBL7603086

CCn1c(=O)n(CCOCCOC)c(=O)c2c1ncn2Cc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.62
MEN1 O00255 4/20 0.62
POLB P06746 2/20 0.56
HIF1A Q16665 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53
ADORA2B P29275 2/20 0.53
RXFP1 Q9HBX9 1/20 0.53
ALDH1A1 P00352 3/20 0.52
CNOT7 Q9UIV1 1/20 0.52
PDE1A P54750 1/20 0.52
PDE1B Q01064 1/20 0.52
PDE1C Q14123 1/20 0.52
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
PDE4A P27815 1/20 0.47
ADORA2A P29274 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1947176 0.89 KMT2A (0.71) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7608527 0.86 POLB (0.59) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL555093 0.84 ALDH1A1 (0.65) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7604892 0.83 KMT2A (0.61) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL555902 0.83 PDE1A (0.70) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7605727 0.82 KMT2A (0.55) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7603804 0.81 POLB (0.67) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7457961 0.81 POLB (0.53) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL1944712 0.81 POLB (0.70) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL8655623 0.81 POLB (0.51) KMT2AMEN1POLBHIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed